Search results
10 Best CBD Oil for Dogs: Best for Anxiety, Pain & Arthritis
The New York Observer· 3 days agoCBD oil for dogs is a novel concept, but animals have the same endocannabinoid system found in humans. With that in mind, dogs can enjoy the benefits of CBD tincture, CBD hemp oil and even CBD ...
AI Will Transform The Federal Government Sooner Than You Think
Forbes· 2 days agoAI is coming to the Government faster than you think. The U.S. federal government is actively...
Monteris Medical Announces Market Release of NeuroBlate NB3 FullFire 1.6mm Laser Probe, Smallest...
Tri-County Times· 1 day agoMonteris Medical, the leader in image guided laser interstitial thermal therapy (LITT), announced today the commercial release of its NeuroBlate® NB3™ FullFire® 1.6mm laser probe, the company's ...
How worrying is bird flu's jump to dairy cows? Here's what experts say
Phys.org· 7 days agoDepartment of Agriculture's tracker showed on Tuesday. On Tuesday, the Food and Drug Administration...
Earnings call: G1 Therapeutics reports growth and optimistic outlook By Investing.com
Investing.com· 15 hours agoG1 Therapeutics (NASDAQ:GTHX) has reported promising financial results in their first-quarter...
$147 million fund manager finds bargains in small-cap stocks
TheStreet via Yahoo Finance· 4 days agoThe cell therapy market is growing rapidly, 20% annually, because of the drugs’ [effectiveness.]...
Acurx Pharmaceuticals Announces Presentation of Ibezapolstat Phase 2 Clinical Trial Results at...
WFRV 5 Green Bay· 4 hours agoAcurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ("Acurx" or the "Company"), a clinical stage biopharmaceutical company developing a new class of antibiotics for difficult-to-treat bacterial infections ...
$776 million fund manager finds bargains in small-cap stocks
TheStreet via Yahoo Finance· 4 days agoThe cell therapy market is growing rapidly, 20% annually, because of the drugs’ [effectiveness]....
Patient-Reported Outcomes in Heart Failure: How Do You Feel?
Medscape· 1 day agoDrs Ileana Piña and Alexander Sandhu discuss the PRO-HF trial and potential discrepancies between...
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock...
St. Joseph News-Press· 2 days agoSHELTON, CT / ACCESSWIRE / April 30, 2024 / NanoViricides, Inc. (NYSE Amer: NNVC ) (the "Company"),...